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INTRODUCTION
Over the past decade the diagnosis of infectious
endocarditis (IE) has become increasingly stan-
dardised [1,2]. This has been assisted by advances
in echocardiography and blood culture technol-
ogy as well as diagnostic criteria.
In an effort to increase diagnostic accuracy and
efﬁciency we developed a diagnostic kit to be
utilised in all patients with suspected IE to detect
all documentable causes of IE. The speciﬁc objec-
tive of this approach was to diminish the propor-
tion of negative blood cultures in endocarditis
and to know the prevalence of Coxiella burnetii
and Bartonella species in cases of infective endo-
carditis in Marseilles.
PATIENTS AND METHODS
From April 1994 to December 2007, all patients with a
suspected diagnosis of IE admitted to La Timone hospital, a
university-based tertiary care medical centre in Marseilles,
France, were prospectively enrolled and followed-up for
1 year. A questionnaire containing clinical, diagnostic and
epidemiological data was completed. A history of underlying
conditions (predisposing heart condition, immunocompro-
mised situation), clinical symptoms and antimicrobial use
was carefully determined.
Patients with suspected IE underwent standardised testing
using a diagnostic kit comprised of three blood cultures
collected over 4 h and serologic tests including C. burnetii,
Bartonella sp. and rheumatoid factor [4]. Patients were classi-
ﬁed according to the modiﬁed Duke criteria [1]. Among
patients classiﬁed as possible IE, only those patients with
either the presence of a major Duke criterion, or echocardio-
graphical abnormalities, or a documented infection, were
treated. All patients with a diagnosis of possible IE were
followed for a minimum of 6 months.
RESULTS
This kit was used in 3450 patients with suspected
IE over a 13-year period. Using the modiﬁed
Duke criteria, deﬁnite IE was diagnosed in 671
patients (19.4%). An aetiologic diagnosis was
determined by blood culture in 533 cases
(79.4%), and by serologic testing in 43 cases
(6.4%) (35 C. burnetii, ﬁve Bartonella quintana and
three Bartonella henselae) (Table 1). Two patients
were found to have dual infection with strepto-
cocci and C. burnetii (Streptococcus bovis and
S. mitis). Among the 533 organisms isolated from
blood cultures, S. aureus was the microorganism
most frequently isolated from blood (22%), fol-
lowed by S. bovis (19%), viridans streptococci
(14%), coagulase-negative staphylococci (14%),
Enterococcus faecalis (8%), E. coli (3%) and the
organisms from the HACEK group (2%).
DISCUSSION
Because the classiﬁcation of patients with sus-
pected IE using the modiﬁed Duke criteria is
dependent on a uniformly comprehensive evalu-
ation, we felt that the use of a diagnostic kit
including serologies was the only method able to
accomplish this. Serological evaluation was criti-
cal in the diagnosis of blood culture negative IE,
especially for the diagnosis of Q fever and
Bartonella endocarditis [2,3]. We also conﬁrmed
that only high titres to Bartonella are indicative of
IE and that titres below 400 lack speciﬁcity [3]. In
addition, it allowed the diagnosis of double
infections with Streptococcus and C. burnetii (doc-
umented by valve culture) in two patients. The
strategy with the systematic use of C. burnetii and
Bartonella species serologies enables the clinician
to start a speciﬁc therapy earlier than by using the
conventional diagnosis strategy consisting of
performing serological testing only if blood cul-
tures are negative [4]. To shorten the duration of
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hospital stay of IE patients just by 1 day would
largely cover the extra costs represented by the
systematic realisation of serological testing [4].
CONCLUSION
The utilisation of a diagnostic kit incorporating
C. burnetii and Bartonella species serologic tests in
the evaluation of patients with suspected IE has
resulted in the establishment of an aetiologic
diagnosis for 85.8% of patients with deﬁnite
IE. The prevalence of C. burnetii and Bartonella
species in cases of infective endocarditis in
Marseilles (1994–2007) is 6.4% of deﬁnite IE
diagnosed in 671 patients.
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Table 1. Kits utilised in patients with suspected IE over the 13-year period and prevalence of Coxiella burnetii and
Bartonella spp as cases of deﬁnite IE
94 95 96 97 98 99 00 01 02 03 04 05 06 07 Total
Kits 57 145 111 124 96 135 209 226 258 312 322 532 489 434 3450
Deﬁnite IE 24 31 19 17 14 41 33 65 67 67 41 93 88 71 671
C. Burnetii endocarditis 3 2 2 1 1 2 4 3 4 3 4 1 1 4 35
B. quintana endocarditis 0 0 0 0 0 1 1 0 1 0 0 1 1 0 5
B. henselae endocarditis 0 1 0 0 0 0 0 0 0 1 0 1 0 0 3
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